Sana Biotechnology Stock Analysis

Sana Stock Analysis Notes

About 92.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.99. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sana Biotechnology recorded a loss per share of 1.4. The entity had not issued any dividends in recent years. Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company was incorporated in 2018 and is headquartered in Seattle, Washington. Sana Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 461 people. To find out more about Sana Biotechnology contact Steven MD at 206 701 7914 or learn more at https://www.sana.com.

Sana Biotechnology Investment Alerts

Sana Biotechnology Upcoming and Recent Events

Sana Largest EPS Surprises

View All Earnings Estimates

Sana Biotechnology Environmental, Social, and Governance (ESG) Scores

Sana Stock Institutional Investors

Note, although Sana Biotechnology's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Sana Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 582.73 M.

Sana Profitablity

Management Efficiency

Sana Biotechnology has return on total asset (ROA) of (0.3115) % which means that it has lost $0.3115 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.929) %, meaning that it created substantial loss on money invested by shareholders. Sana Biotechnology's management efficiency ratios could be used to measure how well Sana Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. As of November 25, 2024, Return On Tangible Assets is expected to decline to -0.81. In addition to that, Return On Capital Employed is expected to decline to -0.69. At present, Sana Biotechnology's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 361.6 M, whereas Non Currrent Assets Other are forecasted to decline to about 6.3 M.

Technical Drivers

As of the 25th of November, Sana Biotechnology has the Risk Adjusted Performance of (0.17), variance of 20.74, and Coefficient Of Variation of (422.73). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sana Biotechnology, as well as the relationship between them.

Sana Biotechnology Price Movement Analysis

Sana Biotechnology Insider Trading Activities

Sana Biotechnology Outstanding Bonds

Sana Biotechnology Predictive Daily Indicators

Sana Biotechnology Corporate Filings

Sana Biotechnology Forecast Models

Sana Biotechnology's time-series forecasting models are one of many Sana Biotechnology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sana Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Sana Biotechnology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sana shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Sana Biotechnology. By using and applying Sana Stock analysis, traders can create a robust methodology for identifying Sana entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Sana analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Sana analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Sana Biotechnology stock analysis indicators help investors evaluate how Sana Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Sana Biotechnology shares will generate the highest return on investment. By understating and applying Sana Biotechnology stock analysis, traders can identify Sana Biotechnology position entry and exit signals to maximize returns.

When running Sana Biotechnology's price analysis, check to measure Sana Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sana Biotechnology is operating at the current time. Most of Sana Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sana Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sana Biotechnology's price. Additionally, you may evaluate how the addition of Sana Biotechnology to your portfolios can decrease your overall portfolio volatility.